Inactive Instrument

News Protea Biosciences Group Inc OTC Bulletin Board

Equities

End-of-day quote OTC Bulletin Board Other stock markets
-	-

2018	Summit Resources Inc cancelled the acquisition of all assets of Protea Biosciences Group, Inc (OTCPK:PRGB.Q).	CI
2018	Protea Biosciences, Inc. Emerged from Bankruptcy	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Summit Resources Inc cancelled the acquisition of all assets of Protea Biosciences Group, Inc (OTCPK:PRGB.Q).	18-07-25	CI
Protea Biosciences, Inc. Emerged from Bankruptcy	18-02-01	CI
Motion for Asset Sale Approved for Protea Biosciences, Inc.	18-01-25	CI
Final DIP Financing Approved for Protea Biosciences, Inc.	18-01-19	CI
Bidding Procedure Approved for Protea Biosciences, Inc.	17-12-13	CI
Interim DIP Financing Approved for Protea Biosciences, Inc.	17-12-12	CI
Protea Biosciences Group, Inc Announces the Resignation of David Halverson as President	17-12-05	CI
Motion for Asset Sale Filed by Protea Biosciences, Inc.	17-12-05	CI
Motion for Joint Administration Approved for Protea Biosciences, Inc.	17-12-04	CI
Summit Resources Inc entered into asset purchase agreement to acquire all assets of Protea Biosciences Group, Inc (OTCPK:PRGB.Q) for $1.3 million.	17-12-04	CI
Protea Biosciences, Inc. Announces Resignation of Patrick Gallagher as Member of the Board	17-12-01	CI
Motion for Joint Administration Filed by Protea Biosciences, Inc.	17-12-01	CI
Protea Biosciences, Inc. Filed for Bankruptcy	17-11-30	CI
Protea Biosciences Group, Inc Announces Resignation of Stephen Turner as Chief Executive Officer and Chairman of the Board	17-10-26	CI
Protea Biosciences Group, Inc. Announces Clinical Assay Development Plans	17-10-10	CI
Protea Biosciences Group, Inc. Announces Resignation of Steve Anoline as Member of the Board	17-10-04	CI
Protea Biosciences Group, Inc Expands Clinical Study for New Melanoma Test	17-08-22	CI
Protea Biosciences Group, Inc. Enters into Collaboration Research Agreement with Vaccine and Immunotherapy Center	17-08-08	CI
Maged Shenouda Resigns as Director of Protea Biosciences Group, Inc	17-06-28	CI
Protea Biosciences Group, Inc Introduces New Molecular Imaging Technology	17-06-21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Protea Biosciences Group Inc OTC Bulletin Board

Equities

Summary

Filters